Zepbound® (tirzepatide) | 4 vials | 12.5 mg

Name: Zepbound® (tirzepatide) | 4 vials | 12.5 mg
SKU: 120
Availability: InStock

£499.00

Zepbound® (tirzepatide) 12.5 mg is an injection that people who are obese or overweight and have related health problems can get once a week with a prescription that is approved by the FDA to help them control their weight. It comes in 4 pre-filled vials and is usually used for 28 days. When paired with diet and exercise, it helps reduce hunger, boosts feelings of fullness, and supports healthy blood sugar levels.

Category: Zepbound Tags: 12.5 mg tirzepatide, appetite suppression, FDA approved weight loss, GLP-1 GIP agonist, obesity treatment, prescription weight management, tirzepatide injection, weekly weight loss injection, weight loss medication, Zepbound

Description
Reviews (0)

Tirzepatide Zepbound Weekly Injection 12.5 mg (4 Vials)

FDA-Approved Prescription for Chronic Weight Management

Tirzepatide Zepbound is an FDA-approved injectable medication developed for long-term weight management in adults with obesity or overweight. It is prescribed for individuals who also have at least one weight-related medical condition, including type 2 diabetes, high blood pressure, or high cholesterol. When used as directed, Zepbound® supports sustainable, clinically proven weight loss.

Advanced Dual GIP & GLP-1 Receptor Agonist

Each vial contains 12.5 mg of tirzepatide, a dual GIP and GLP-1 receptor agonist that targets key metabolic pathways involved in appetite and glucose regulation. This dual-action mechanism helps to:

Reduce appetite and food cravings
Increase satiety and feelings of fullness
Support healthy blood sugar levels
Improve overall metabolic balance

Convenient Once-Weekly Injection

Zepbound® is administered once weekly via subcutaneous injection, offering a convenient dosing schedule that fits easily into most treatment plans. The medication is supplied in pre-filled injection vials, ensuring consistent and accurate dosing as prescribed by a healthcare professional.

Product Details & Specifications

Medication Name: Zepbound® (tirzepatide)
Dosage Strength: 12.5 mg per vial
Dosage Form: Pre-filled injection vials
Quantity: 4 vials
Administration: Weekly subcutaneous injection
Treatment Duration: Typical 28-day supply

Clinically Proven Support for Sustainable Weight Loss

Zepbound® is designed for chronic weight management rather than short-term use. When combined with a reduced-calorie diet and increased physical activity, it helps patients achieve meaningful weight loss while supporting long-term metabolic and overall health.